Cited by 66Medication Adherence and ComplianceDiabetes Management and ResearchDiabetes Management and Education

Nonadherence to Insulin Therapy Detected by Bluetooth-Enabled Pen Cap Is Associated With Poor Glycemic Control

Munshi, Medha N., Slyne, Christine, Greenberg, Jordan M., Greaves, Tori, Lee, Ariel, Carl, Sam, Atakov-Castillo, Astrid, Toschi, Elena·2019·Diabetes Care

Abstract

OBJECTIVE: To objectively evaluate adherence to timing and dosing of insulin by using Bluetooth pen caps and examine factors related to adherence. RESEARCH DESIGN AND METHODS: Bluetooth-enabled insulin pen caps were used in younger (ages 18–35 years) and older (ages ≥65 years) adults on two or more insulin injections per day. RESULTS: We evaluated 75 participants with diabetes, 42 younger (29 ± 4 years) and 33 older (73 ± 7 years). Nonadherence was found in 24% of bolus (Apidra) doses and 36% of basal (Lantus) doses. We divided participants into tertiles on the basis of overall adherence, with the most adherent tertile having 85% dose adherence compared with 49% in the least adherent tertile (P < 0.001). Participants in the most adherent tertile had better glycemic control than those in the least adherent tertile (7.7 ± 1.1% [61 ± 12 mmol/mol] vs. 8.6 ± 1.5% [70 ± 16.4 mmol/mol], P < 0.03). CONCLUSIONS: Nonadherence to insulin dosing and timing can be objectively assessed by Bluetooth pen caps and is associated with poor glycemic control.

Integrity signals

Registry

Crossref · 10.2337/dc18-1631

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Research from individuals using multiple daily injection therapy with continuous glucose monitoring and connected insulin pen or cap devices revealed that missed, mistimed, and mismatched insulin bolus doses are common and occur in both older and younger populations with T1D or T2D, and are associated with higher A1C.

    “Research from individuals using MDI therapy with CGM and connected insulin pen or cap devices revealed that missed, mistimed, and mismatched insulin bolus doses are common and occur in both older and younger populations with T1D or T2D, and are associated with higher A1C.13–18”
  • Difficulties with insulin dosing and inaccurate dose timing result in poor glycemic control for people with diabetes.

    “Difficulties with insulin dosing and inaccurate dose timing have been shown to result in poor glycemic control for people with diabetes.5,6”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Munshi, M. N., Slyne, C., Greenberg, J. M., Greaves, T., Lee, A., Carl, S., Atakov-Castillo, A., & Toschi, E.
Affiliations
Joslin Diabetes Center (US)
Corresponding author
Munshi, Medha N.
Venue
Diabetes Care
Published
2019-03-12
Volume
42
Issue
6
Pages
1129-1131
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2921048232
Cited by
66
References
6
Citations by year
2026: 7 · 2025: 6 · 2024: 8 · 2023: 15 · 2022: 8 · 2021: 13 · 2020: 7 · 2019: 2
FWCI
7.69
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sanofi
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
insulin therapy, medication adherence, glycemic control, bolus insulin, basal insulin, type 1 diabetes, type 2 diabetes, older adults, young adults
MeSH terms
Insulin Glargine, Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Injections, Insulin, Male, Cohort Studies, Drug Delivery Systems, Drug Monitoring, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review